Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Translational Research

New drug for inherited breast and ovarian cancers shows promise in early trials

A new experimental drug called a PARP inhibitor, has shown promising results against some inherite cancers.

UK-NZ collaboration to home in on new anti-cancer drug for leukaemia

Cancer Research Technology (CRT) - Cancer Research UK's development and commercialisation arm has teamed up with The University of Auckland to advance the discovery of new...

Deal struck for new investigational anti-cancer drug to target leukaemia and lymphoma

CANCER RESEARCH UK and Cancer Research Technology (CRT), the charityїs development and commercialisation arm, are to undertake a phase I clinical trial of an...

Channel 4 & Cancer Research UK to launch 'Stand Up To Cancer' in the UK

Channel 4 and Cancer Research UK are joining forces to launch ‘Stand Up To Cancer’ in the UK. Television, music and film stars will come together in October in a new...

UKCMRI to be renamed The Francis Crick Institute

The UK Centre for Medical Research and Innovation, is to be re-named The Francis Crick Institute in honour of one of the nation's greatest scientists.

Call for nominations as Cancer Research UK announce new prestigious awards

Cancer Research UK today (Tuesday) announced the launch of three new prestigious awards that will recognise world leading cancer researchers and the scientists of tomorrow...

Drug trial offers first hope for pancreatic cancer patients

Chemotherapy after surgery almost trebles survival rates for pancreatic cancer according to new research published in the New England Journal of Medicine 1.

Cancer Research UK receives largest ever donation

Cancer Research UK has been given a gift of Ј10 million from one of its supporters. This is the largest one-off donation the charity has ever received, and comes alongside...

Experimental drug shrinks tumours in women with hereditary breast and ovarian cancers

An experimental drug called olaparib has been shown to shrink tumours in women whose advanced cancers were caused by faults in their BRCA genes.

Cancer Research UK leads global lung cancer drug trial

Cancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treatment. The...

Pages